Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease

Steven T. Leach School of Women's and Children's Health, University of New South Wales, Sydney, Australia

Zheng Yang Inflammatory Disease Research Unit, School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia

Isabella Messina Department of Gastroenterology, Sydney Children's Hospital Randwick, NSW, Australia

Changjie Song Inflammatory Disease Research Unit, School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia

Carolyn L. Geczy Inflammatory Disease Research Unit, School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia

Anne M. Cunningham School of Women's and Children's Health, University of New South Wales, Sydney, Australia

Andrew S. Day School of Women's and Children's Health, University of New South Wales, Sydney, Australia; Department of Gastroenterology, Sydney Children's Hospital Randwick, NSW, AustraliaCorrespondence[email protected]

, FRACP , MB , ChB , MD show all

Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date